{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T16:01:05Z","timestamp":1714924865653},"reference-count":130,"publisher":"Elsevier","isbn-type":[{"value":"9780444632692","type":"print"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1016\/b978-0-444-63269-2.00015-5","type":"book-chapter","created":{"date-parts":[[2015,2,8]],"date-time":"2015-02-08T20:44:29Z","timestamp":1423428269000},"page":"109-131","source":"Crossref","is-referenced-by-count":0,"title":["Lymphocytes and Infection in Autoimmune Diseases"],"prefix":"10.1016","author":[{"given":"Graziela","family":"Carvalheiras","sequence":"first","affiliation":[]},{"given":"Mariana","family":"Brand\u00e3o","sequence":"additional","affiliation":[]},{"given":"Vital","family":"Domingues","sequence":"additional","affiliation":[]},{"given":"Esmeralda","family":"Neves","sequence":"additional","affiliation":[]},{"given":"J\u00falia","family":"Vasconcelos","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Almeida","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Vasconcelos","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0010","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0015","first-page":"94","article-title":"Regulatory T, cells vs Th17: differentiation of Th17 versus Treg, are the mutually exclusive?","volume":"2","author":"Zheng","year":"2013","journal-title":"Am J Clin Exp Immunol"},{"issue":"13","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0020","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1182\/blood-2012-09-378653","article-title":"Essentials of Th17 cell commitment and plasticity","volume":"121","author":"Muranski","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0025","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.4049\/jimmunol.174.4.1775","article-title":"B cell selection and susceptibility to autoimmunity","volume":"174","author":"Grimaldi","year":"2005","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cytogfr.2013.04.003","article-title":"The BAFF\/APRIL system: emerging functions beyond B cell biology and autoimmunity","volume":"24","author":"Vincent","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0035","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s10067-013-2176-8","article-title":"NK cells dysfunction in systemic lupus erythematosus: relation to disease activity","volume":"32","author":"Henriques","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/art.22326","article-title":"Natural killer T cells in families of patients with systemic lupus erythematosus: their possible role in regulation of IGG production","volume":"56","author":"Green","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/B978-0-444-63269-2.00015-5_bb0045","doi-asserted-by":"crossref","first-page":"478429","DOI":"10.1155\/2012\/478429","article-title":"Modulatory function of invariant natural killer T cells in systemic lupus erythematosus","volume":"2012","author":"Chuang","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"5","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0050","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.4049\/jimmunol.1201718","article-title":"Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells","volume":"190","author":"Parekh","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/B978-0-444-63269-2.00015-5_bb0055","doi-asserted-by":"crossref","first-page":"535738","DOI":"10.1155\/2013\/535738","article-title":"Epstein\u2013Barr virus in systemic autoimmune diseases","volume":"2013","author":"Draborg","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/B978-0-444-63269-2.00015-5_bb0060","first-page":"189096","article-title":"CD8+ T-cell deficiency, Epstein\u2013Barr virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis","volume":"2012","author":"Pender","year":"2012","journal-title":"Autoimmune Dis"},{"issue":"8","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0065","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1182\/blood-2013-01-474213","article-title":"Autoantibodies against cytokines: back to human genetics","volume":"121","author":"Puel","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/0961203308100660","article-title":"Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia","volume":"18","author":"Al Arfaj","year":"2009","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1191\/0961203302lu161oa","article-title":"Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States","volume":"11","author":"Cooper","year":"2002","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.md.0000104742.42401.e2","article-title":"The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among \u201cHispanics\u201d","volume":"83","author":"Pons-Estel","year":"2004","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0085","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00296-010-1755-0","article-title":"Long-term efficacy of anti-CD20 antibodies in refractory lupus nephritis","volume":"32","author":"Arce-Salinas","year":"2012","journal-title":"Rheumatol Int"},{"issue":"12","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0090","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1093\/rheumatology\/keq269","article-title":"The management of peripheral blood cytopenias in systemic lupus erythematosus","volume":"49","author":"Hepburn","year":"2010","journal-title":"Rheumatology"},{"issue":"2A","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0095","first-page":"200","article-title":"CD4 lymphocytopenia in systemic lupus erythematosus","volume":"34","author":"Ferreira","year":"2009","journal-title":"Acta Reumatol Port"},{"issue":"8","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0100","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/rheumatology\/kel016","article-title":"Moderate and severe neutropenia in patients with systemic lupus erythematosus","volume":"45","author":"Martinez-Banos","year":"2006","journal-title":"Rheumatology"},{"issue":"5239","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0105","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/2251255a0","article-title":"Lymphocyte cytotoxic antibodies in systemic lupus erythematosus","volume":"225","author":"Mittal","year":"1970","journal-title":"Nature"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/art.1780150302","article-title":"Relationship of the clinical course of systemic lupus erythematosus to the presence of circulating lymphocytotoxic antibodies","volume":"15","author":"Butler","year":"1972","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0115","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/art.1780180609","article-title":"Association of cold-reactive antilymphocyte antibodies with lymphopenia in systemic lupus erythematosus","volume":"18","author":"Winfield","year":"1975","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0120","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1191\/096120300674499064","article-title":"Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies","volume":"9","author":"Bengtsson","year":"2000","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0125","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/0961203306071916","article-title":"Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia","volume":"15","author":"Garcia-Valladares","year":"2006","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.autrev.2006.09.008","article-title":"The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias","volume":"6","author":"Ruiz-Arguelles","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0135","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"issue":"275","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0140","first-page":"319","article-title":"SLE: a rheumatological view. Analysis of the clinical features, serology and immunogenetics of 100 SLE patients during long-term follow-up","volume":"74","author":"Worrall","year":"1990","journal-title":"Q J Med"},{"issue":"291","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0145","first-page":"605","article-title":"Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus","volume":"80","author":"Nossent","year":"1991","journal-title":"Q J Med"},{"issue":"12","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0150","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/rheumatology\/39.12.1316","article-title":"Prognostic parameters for flare in systemic lupus erythematosus","volume":"39","author":"Mirzayan","year":"2000","journal-title":"Rheumatology"},{"issue":"5 Suppl. 39","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0155","first-page":"S120","article-title":"Assessment of systemic lupus erythematosus","volume":"23","author":"Lam","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0160","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/art.22224","article-title":"Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual","volume":"55","author":"Vila","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF02200996","article-title":"Systemic lupus erythematosus. Follow-up study of 148 patients. II: predictive factors of importance for course and outcome","volume":"6","author":"Halberg","year":"1987","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/art.1780210302","article-title":"Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance","volume":"21","author":"Rivero","year":"1978","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0175","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/096120339700600304","article-title":"Vasculitis in systemic lupus erythematosus","volume":"6","author":"Drenkard","year":"1997","journal-title":"Lupus"},{"issue":"8","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0180","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1007\/s00415-002-0781-6","article-title":"Increased lymphocyte death by neglect-apoptosis is associated with lymphopenia and autoantibodies in lupus patients presenting with neuropsychiatric manifestations","volume":"249","author":"Silva","year":"2002","journal-title":"J Neurol"},{"issue":"9","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0185","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/rheumatology\/kem182","article-title":"Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients","volume":"46","author":"Yu","year":"2007","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/qjmed\/hci155","article-title":"Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus","volume":"99","author":"Ng","year":"2006","journal-title":"QJM"},{"issue":"5","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0195","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/qjmed\/hct046","article-title":"Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study","volume":"106","author":"Merayo-Chalico","year":"2013","journal-title":"QJM"},{"issue":"5","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0200","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients","volume":"82","author":"Cervera","year":"2003","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0205","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1191\/0961203303lu452oa","article-title":"Hospitalization of individuals with systemic lupus erythematosus: characteristics and predictors of outcome","volume":"12","author":"Edwards","year":"2003","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0210","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.0007-0963.2004.05883.x","article-title":"The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship","volume":"150","author":"Wouters","year":"2004","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0215","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s12016-012-8327-x","article-title":"Systemic lupus erythematosus, progressive multifocal leukoencephalopathy, and T-CD4+ lymphopenia","volume":"43","author":"Brandao","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"issue":"10","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0220","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.4049\/jimmunol.165.10.5970","article-title":"Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus","volume":"165","author":"Odendahl","year":"2000","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0225","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/09511920410001713538","article-title":"Clinical significance of circulating dendritic cells in patients with systemic lupus erythematosus","volume":"13","author":"Robak","year":"2004","journal-title":"Mediators Inflamm"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0230","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF01533366","article-title":"T helper cell dysfunction in systemic lupus erythematosus (SLE): relation to disease activity","volume":"14","author":"Bermas","year":"1994","journal-title":"J Clin Immunol"},{"issue":"5","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0235","first-page":"435","article-title":"Disseminated histoplasmosis, lymphopenia and Sjogren's syndrome","volume":"72","author":"Rodrigo","year":"2012","journal-title":"Medicina"},{"issue":"4","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0240","first-page":"726","article-title":"CD4+ T-lymphocytopenia\u2014a frequent finding in anti-SSA antibody seropositive patients with primary Sjogren's syndrome","volume":"31","author":"Mandl","year":"2004","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0245","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/rheumatology\/39.2.142","article-title":"Antibodies to CD4 in primary Sjogren's syndrome","volume":"39","author":"Henriksson","year":"2000","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0250","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/ar1208","article-title":"Lymphopenia and autoimmune diseases","volume":"6","author":"Schulze-Koops","year":"2004","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0255","first-page":"609","article-title":"CD4+ T-lymphocytopenia without HIV infection: increased prevalence among patients with primary Sjogren's syndrome","volume":"13","author":"Kirtava","year":"1995","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0260","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/BOR.0b013e32831cb939","article-title":"Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders","volume":"21","author":"Goyal","year":"2009","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl. 1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0265","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1007\/s10875-007-9167-y","article-title":"Primary immunodeficiencies unravel critical aspects of the pathophysiology of autoimmunity and of the genetics of autoimmune disease","volume":"28","author":"Coutinho","year":"2008","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0270","first-page":"125","article-title":"High prevalence of primary immune deficiencies in children with autoimmune disorders","volume":"29","author":"Barsalou","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl. 1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0275","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1007\/s10875-007-9159-y","article-title":"Autoimmunity in severe combined immunodeficiency (SCID): lessons from patients and experimental models","volume":"28","author":"Milner","year":"2008","journal-title":"J Clin Immunol"},{"issue":"7","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0280","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1182\/blood-2002-05-1583","article-title":"Autoimmunity in severe combined immunodeficiency (SCID)","volume":"100","author":"Elhasid","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0285","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1086\/318120","article-title":"Progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia: a case report and review of reported cases","volume":"31","author":"Haider","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0290","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/2231-0770.114121","article-title":"Idiopathic CD4 lymphocytopenia: spectrum of opportunistic infections, malignancies, and autoimmune diseases","volume":"3","author":"Ahmad","year":"2013","journal-title":"Avicenna J Med"},{"issue":"4","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0295","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.bor.0000231908.57913.2f","article-title":"Idiopathic CD4 lymphocytopenia","volume":"18","author":"Walker","year":"2006","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0300","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/blood-2007-12-127878","article-title":"Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors","volume":"112","author":"Zonios","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0305","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng1601","article-title":"TACI is mutant in common variable immunodeficiency and IgA deficiency","volume":"37","author":"Castigli","year":"2005","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0310","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ng1600","article-title":"Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans","volume":"37","author":"Salzer","year":"2005","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0315","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0320","first-page":"1205","article-title":"Juvenile rheumatoid arthritis and common variable hypogammaglobulinemia","volume":"25","author":"Uluhan","year":"1998","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0325","first-page":"103","article-title":"Clinical and immunological spectrum of common variable immunodeficiency (CVID)","volume":"3","author":"Webster","year":"2004","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"6 Pt. 1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0330","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-3476(05)82002-5","article-title":"A multiinstitutional survey of the Wiskott\u2013Aldrich syndrome","volume":"125","author":"Sullivan","year":"1994","journal-title":"J Pediatr"},{"issue":"5 Pt. 1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0335","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1542\/peds.111.5.e622","article-title":"Autoimmunity in Wiskott\u2013Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients","volume":"111","author":"Dupuis-Girod","year":"2003","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0340","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/ijr.09.72","article-title":"Infection in systemic lupus erythematosus: friend or foe?","volume":"5","author":"Francis","year":"2010","journal-title":"Int J Clin Rheumatol"},{"issue":"7","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0345","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/08916930500285352","article-title":"Infections and SLE","volume":"38","author":"Zandman-Goddard","year":"2005","journal-title":"Autoimmunity"},{"issue":"12","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0350","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1177\/0961203313493032","article-title":"Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies","volume":"22","author":"Danza","year":"2013","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0355","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/SMJ.0b013e318180bcfd","article-title":"Epidemiological, clinical, laboratory findings, and outcomes of disseminated tuberculosis in Tehran, Iran","volume":"101","author":"Hasibi","year":"2008","journal-title":"South Med J"},{"issue":"788","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0360","first-page":"90","article-title":"Significance of haematological manifestations in patients with tuberculosis","volume":"49","author":"Singh","year":"2001","journal-title":"J Assoc Physicians India"},{"issue":"6","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0365","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/00002030-199406000-00019","article-title":"Idiopathic CD4+ T-lymphocyte depletion in a west African population","volume":"8","author":"Djomand","year":"1994","journal-title":"Aids"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0370","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/infdis\/150.3.419","article-title":"Hematologic changes in brucellosis","volume":"150","author":"Crosby","year":"1984","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0375","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01739305","article-title":"Haematological manifestations of childhood brucellosis","volume":"21","author":"al-Eissa","year":"1993","journal-title":"Infection"},{"issue":"4","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0380","first-page":"92","article-title":"The immune status of patients with typhoid fever","author":"Iushchuk","year":"1994","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"issue":"1\u20132","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0385","first-page":"23","article-title":"The white cell count in typhoid fever","volume":"44","author":"Abdool Gaffar","year":"1992","journal-title":"Trop Geogr Med"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0390","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2174\/1570162043351282","article-title":"Cytopenias in HIV infection: mechanisms and alleviation of hematopoietic inhibition","volume":"2","author":"Koka","year":"2004","journal-title":"Curr HIV Res"},{"issue":"9","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0395","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s10067-013-2271-x","article-title":"Systemic lupus erythematosus and HIV infection: a whimsical relationship. Reports of two cases and review of the literature","volume":"32","author":"Carugati","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0400","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/0003-4819-119-1-199307010-00010","article-title":"T-cell subsets in health, infectious disease, and idiopathic CD4+ T lymphocytopenia","volume":"119","author":"Laurence","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/B978-0-444-63269-2.00015-5_bb0405","first-page":"243","article-title":"Measles virus-induced immunosuppression","volume":"330","author":"Schneider-Schaulies","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"issue":"9","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0410","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/rheumatology\/ken231","article-title":"Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population","volume":"47","author":"Takizawa","year":"2008","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0415","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5070\/D32DX685HC","article-title":"Letter: adult measles with a butterfly rash-like appearance","volume":"16","author":"Tsuruta","year":"2010","journal-title":"Dermatol Online J"},{"issue":"12","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0420","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00006454-199912000-00007","article-title":"Disseminated histoplasmosis in infants","volume":"18","author":"Odio","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/B978-0-444-63269-2.00015-5_bb0425","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1475-2875-12-101","article-title":"Predictive value of lymphocytopenia and the neutrophil-lymphocyte count ratio for severe imported malaria","volume":"12","author":"van Wolfswinkel","year":"2013","journal-title":"Malar J"},{"issue":"Suppl. 1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0430","first-page":"21","article-title":"Short-term and long-term safety of glucocorticoids in rheumatoid arthritis","volume":"70","author":"Saag","year":"2012","journal-title":"Bull NYU Hosp Jt Dis"},{"issue":"4","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0435","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1189\/jlb.0208104","article-title":"The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease","volume":"84","author":"Tait","year":"2008","journal-title":"J Leukoc Biol"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0440","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1189\/jlb.0709517","article-title":"Infections and autoimmunity: the multifaceted relationship","volume":"87","author":"Sfriso","year":"2010","journal-title":"J Leukoc Biol"},{"issue":"4","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0445","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0749-0704(02)00022-2","article-title":"Infections in the immunocompromised rheumatologic patient","volume":"18","author":"Greenberg","year":"2002","journal-title":"Crit care Clin"},{"issue":"2","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0450","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10067-013-2352-x","article-title":"The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: a follow-up study","volume":"33","author":"Szalay","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0455","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2249.2010.04309.x","article-title":"Quantitative and functional profiles of CD4+ lymphocyte subsets in systemic lupus erythematosus patients with lymphopenia","volume":"164","author":"Gomez-Martin","year":"2011","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0460","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00296-012-2365-9","article-title":"The effect of various disease-modifying anti-rheumatic drugs on the suppressive function of CD4(+)CD25(+) regulatory T cells","volume":"33","author":"Oh","year":"2013","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0465","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/0961203312470186","article-title":"Increased incidence of herpes zoster among patients with systemic lupus erythematosus","volume":"22","author":"Chakravarty","year":"2013","journal-title":"Lupus"},{"issue":"11","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0470","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1007\/s00296-011-2151-0","article-title":"Factors associated with major infections in patients with granulomatosis with polyangiitis and systemic lupus erythematosus treated for deep organ involvement","volume":"32","author":"Morton","year":"2012","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0475","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2340\/00015555-1454","article-title":"Lymphopaenia, anti-Ro\/anti-RNP autoantibodies, renal involvement and cyclophosphamide use correlate with increased risk of herpes zoster in patients with systemic lupus erythematosus","volume":"93","author":"Hu","year":"2013","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0480","first-page":"1473","article-title":"Immune status and risk for infection in patients receiving chronic immunosuppressive therapy","volume":"32","author":"Gluck","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/B978-0-444-63269-2.00015-5_bb0485","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1741-7015-11-88","article-title":"Biologic therapy for autoimmune diseases: an update","volume":"11","author":"Rosman","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/B978-0-444-63269-2.00015-5_bb0490","doi-asserted-by":"crossref","first-page":"765624","DOI":"10.1155\/2011\/765624","article-title":"The roles of interleukin-6 in the pathogenesis of rheumatoid arthritis","volume":"2011","author":"Hashizume","year":"2011","journal-title":"Arthritis"},{"issue":"9767","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0495","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0500","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/art.21201","article-title":"Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial","volume":"52","author":"Kremer","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0505","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1136\/ard.2010.139345","article-title":"Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial","volume":"70","author":"Kremer","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0510","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/1529-0131(200109)44:9<1998::AID-ART348>3.0.CO;2-T","article-title":"Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia","volume":"44","author":"Isaacs","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0515","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jbspin.2011.12.004","article-title":"Safety of rituximab in rheumatoid arthritis: a long-term prospective single-center study of gammaglobulin concentrations and infections","volume":"79","author":"Isvy","year":"2012","journal-title":"Joint Bone Spine"},{"issue":"12","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0520","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1469-0691.2011.03653.x","article-title":"Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies","volume":"17","author":"Tavazzi","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0525","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/art.34468","article-title":"Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies","volume":"64","author":"Molloy","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0530","first-page":"777","article-title":"Intravenous immune globulin in autoimmune and inflammatory diseases","volume":"368","author":"Gelfand","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0535","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/mnfr.201000174","article-title":"A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency","volume":"55","author":"Schwalfenberg","year":"2011","journal-title":"Mol Nutr Food Res"},{"issue":"5","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0540","doi-asserted-by":"crossref","first-page":"R221","DOI":"10.1186\/ar4060","article-title":"Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation","volume":"14","author":"Terrier","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0545","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/18715281113129990046","article-title":"The role of vitamin D in prevention and treatment of infection","volume":"12","author":"Gunville","year":"2013","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"12","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0550","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1586\/eri.10.102","article-title":"Vitamin D: emerging roles in infection and immunity","volume":"8","author":"Bartley","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"7","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0555","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.autrev.2013.02.001","article-title":"Management of immune cytopenias in patients with systemic lupus erythematosus \u2013 old and new","volume":"12","author":"Newman","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0560","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0268-960X(93)90006-P","article-title":"Haematological manifestations of systemic lupus erythematosus","volume":"7","author":"Keeling","year":"1993","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0565","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.autrev.2008.07.019","article-title":"Infections as triggers and complications of systemic lupus erythematosus","volume":"8","author":"Doria","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0570","first-page":"637","article-title":"Infections and lupus","volume":"48","author":"Le Moing","year":"1998","journal-title":"Rev Prat"},{"issue":"1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0575","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0580","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1378\/chest.118.3.712","article-title":"Peripheral blood CD4+ T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection","volume":"118","author":"Mansharamani","year":"2000","journal-title":"Chest"},{"issue":"8","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0585","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0590","first-page":"246","article-title":"Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases","volume":"21","author":"Godeau","year":"1994","journal-title":"J Rheumatol"},{"issue":"3 Pt. 1","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0595","first-page":"795","article-title":"Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis","volume":"151","author":"Ognibene","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0600","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M","article-title":"Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality","volume":"42","author":"Ward","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0605","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1378\/chest.118.3.704","article-title":"Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states","volume":"118","author":"Mansharamani","year":"2000","journal-title":"Chest"},{"key":"10.1016\/B978-0-444-63269-2.00015-5_bb0610","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2334-4-42","article-title":"Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: a strategy for prevention","volume":"4","author":"Sowden","year":"2004","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0615","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/acr.21857","article-title":"Recent-onset systemic lupus erythematosus complicated by acute respiratory failure","volume":"65","author":"Demoruelle","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"5","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0620","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/RHU.0b013e31817a7e30","article-title":"Prophylactic antibiotic usage for Pneumocystis jirovecii pneumonia in patients with systemic lupus erythematosus on cyclophosphamide: a survey of US rheumatologists and the review of literature","volume":"14","author":"Gupta","year":"2008","journal-title":"J Clin Rheumatol"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0625","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2249.2009.03910.x","article-title":"Safety and efficacy of treatment using interleukin-2 in a patient with idiopathic CD4(+) lymphopenia and Mycobacterium avium-intracellulare","volume":"156","author":"Trojan","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0630","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1046\/j.1365-2249.1999.00886.x","article-title":"Treatment of idiopathic CD4 T lymphocytopenia with IL-2","volume":"116","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"Suppl. 3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0635","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1016\/j.ijid.2009.08.004","article-title":"Treatment of relapsing Mycobacterium avium infection with interferon-gamma and interleukin-2 in an HIV-negative patient with low CD4 syndrome","volume":"14","author":"Sternfeld","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"1\u20132","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0640","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cca.2010.09.002","article-title":"IL-7 and lymphopenia","volume":"412","author":"Ponchel","year":"2011","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0645","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.autrev.2007.11.004","article-title":"Preventive strategies in systemic lupus erythematosus","volume":"7","author":"Doria","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0650","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement","volume":"36","author":"Solovic","year":"2010","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/B978-0-444-63269-2.00015-5_bb0655","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.berh.2011.10.004","article-title":"Anti-TNF therapy","volume":"25","author":"Thalayasingam","year":"2011","journal-title":"Best Pract Res Clin Rheumatol"}],"container-title":["Infection and Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780444632692000155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780444632692000155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T22:22:15Z","timestamp":1691101335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780444632692000155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9780444632692"],"references-count":130,"URL":"https:\/\/doi.org\/10.1016\/b978-0-444-63269-2.00015-5","relation":{},"subject":[],"published":{"date-parts":[[2015]]}}}